

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 7.10116464 |
| 2 | cellular ketone body metabolic process (GO:0046950) | 5.57106114 |
| 3 | ketone body metabolic process (GO:1902224) | 4.93646649 |
| 4 | platelet dense granule organization (GO:0060155) | 4.62488631 |
| 5 | water-soluble vitamin biosynthetic process (GO:0042364) | 4.41945975 |
| 6 | regulation of heat generation (GO:0031650) | 4.35583585 |
| 7 | regulation of penile erection (GO:0060405) | 4.24374058 |
| 8 | cytidine metabolic process (GO:0046087) | 4.09268810 |
| 9 | cytidine catabolic process (GO:0006216) | 4.09268810 |
| 10 | cytidine deamination (GO:0009972) | 4.09268810 |
| 11 | behavioral response to nicotine (GO:0035095) | 3.97775673 |
| 12 | behavioral response to ethanol (GO:0048149) | 3.96989466 |
| 13 | somite development (GO:0061053) | 3.96106099 |
| 14 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.93945455 |
| 15 | detection of light stimulus involved in visual perception (GO:0050908) | 3.93945455 |
| 16 | response to nerve growth factor (GO:1990089) | 3.85132378 |
| 17 | cellular response to nerve growth factor stimulus (GO:1990090) | 3.85132378 |
| 18 | negative regulation of mast cell activation (GO:0033004) | 3.83947751 |
| 19 | cellular response to ATP (GO:0071318) | 3.77644851 |
| 20 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.61585184 |
| 21 | positive regulation of T cell cytokine production (GO:0002726) | 3.56344670 |
| 22 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.52730014 |
| 23 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.47767693 |
| 24 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 3.44133042 |
| 25 | tachykinin receptor signaling pathway (GO:0007217) | 3.39215558 |
| 26 | mannosylation (GO:0097502) | 3.32387217 |
| 27 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.29031273 |
| 28 | nucleoside diphosphate catabolic process (GO:0009134) | 3.28723277 |
| 29 | regulation of immunoglobulin secretion (GO:0051023) | 3.12763735 |
| 30 | regulation of cilium movement (GO:0003352) | 3.12187071 |
| 31 | rRNA modification (GO:0000154) | 3.09721792 |
| 32 | regulation of action potential (GO:0098900) | 3.04259867 |
| 33 | regulation of meiosis I (GO:0060631) | 3.04130719 |
| 34 | response to xenobiotic stimulus (GO:0009410) | 3.03752464 |
| 35 | maturation of 5.8S rRNA (GO:0000460) | 3.00177472 |
| 36 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.98607155 |
| 37 | pseudouridine synthesis (GO:0001522) | 2.98463411 |
| 38 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.97814644 |
| 39 | purine nucleotide salvage (GO:0032261) | 2.96678276 |
| 40 | response to pheromone (GO:0019236) | 2.94470595 |
| 41 | aggressive behavior (GO:0002118) | 2.93158072 |
| 42 | protein neddylation (GO:0045116) | 2.93060131 |
| 43 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.90229624 |
| 44 | maternal behavior (GO:0042711) | 2.89103878 |
| 45 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.85417435 |
| 46 | negative regulation of dendrite development (GO:2000171) | 2.85084303 |
| 47 | replication fork processing (GO:0031297) | 2.80835996 |
| 48 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.75039326 |
| 49 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.73799973 |
| 50 | intestinal epithelial cell development (GO:0060576) | 2.73757032 |
| 51 | oxidative phosphorylation (GO:0006119) | 2.70327161 |
| 52 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 2.69609126 |
| 53 | substrate-independent telencephalic tangential migration (GO:0021826) | 2.69609126 |
| 54 | regulation of catecholamine metabolic process (GO:0042069) | 2.68650676 |
| 55 | regulation of dopamine metabolic process (GO:0042053) | 2.68650676 |
| 56 | adenosine metabolic process (GO:0046085) | 2.67581797 |
| 57 | regulation of calcium-mediated signaling (GO:0050848) | 2.64119501 |
| 58 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.63075085 |
| 59 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.63075085 |
| 60 | parental behavior (GO:0060746) | 2.59138761 |
| 61 | nucleotide transmembrane transport (GO:1901679) | 2.55414310 |
| 62 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.53892464 |
| 63 | response to amphetamine (GO:0001975) | 2.52924626 |
| 64 | sulfation (GO:0051923) | 2.50950690 |
| 65 | cornea development in camera-type eye (GO:0061303) | 2.48292636 |
| 66 | fear response (GO:0042596) | 2.47818501 |
| 67 | serotonin receptor signaling pathway (GO:0007210) | 2.47756768 |
| 68 | regulation of glycogen (starch) synthase activity (GO:2000465) | 2.47624033 |
| 69 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.47129134 |
| 70 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.47129134 |
| 71 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.43581365 |
| 72 | regulation of cell maturation (GO:1903429) | 2.43393757 |
| 73 | regulation of uterine smooth muscle contraction (GO:0070472) | 2.42872327 |
| 74 | sulfate transmembrane transport (GO:1902358) | 2.42834323 |
| 75 | positive regulation of prostaglandin secretion (GO:0032308) | 2.40625802 |
| 76 | photoreceptor cell maintenance (GO:0045494) | 2.40604770 |
| 77 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.40394755 |
| 78 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.40043426 |
| 79 | postsynaptic membrane organization (GO:0001941) | 2.38882491 |
| 80 | negative regulation of membrane potential (GO:0045837) | 2.35862712 |
| 81 | ubiquinone biosynthetic process (GO:0006744) | 2.33945257 |
| 82 | positive regulation of defense response to virus by host (GO:0002230) | 2.33942682 |
| 83 | purine-containing compound salvage (GO:0043101) | 2.32223818 |
| 84 | behavioral defense response (GO:0002209) | 2.31700548 |
| 85 | behavioral fear response (GO:0001662) | 2.31700548 |
| 86 | lateral ventricle development (GO:0021670) | 2.31400741 |
| 87 | neural tube formation (GO:0001841) | 2.31167233 |
| 88 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.29991270 |
| 89 | adult feeding behavior (GO:0008343) | 2.29948736 |
| 90 | regulation of neurotransmitter uptake (GO:0051580) | 2.29085850 |
| 91 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.28532354 |
| 92 | brain morphogenesis (GO:0048854) | 2.28140314 |
| 93 | ubiquinone metabolic process (GO:0006743) | 2.27478609 |
| 94 | negative regulation of T cell apoptotic process (GO:0070233) | 2.27051104 |
| 95 | adaptation of signaling pathway (GO:0023058) | 2.26999105 |
| 96 | regulation of microtubule-based movement (GO:0060632) | 2.26776512 |
| 97 | regulation of pigment cell differentiation (GO:0050932) | 2.25244010 |
| 98 | GPI anchor metabolic process (GO:0006505) | 2.24915018 |
| 99 | dopaminergic neuron differentiation (GO:0071542) | 2.24191039 |
| 100 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.24099763 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 4.33437145 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.10201974 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.09939268 |
| 4 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.86265135 |
| 5 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.85390649 |
| 6 | VDR_22108803_ChIP-Seq_LS180_Human | 2.76689906 |
| 7 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.52065119 |
| 8 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.48106234 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.47310520 |
| 10 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.39097940 |
| 11 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.32141396 |
| 12 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.27137652 |
| 13 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.22802713 |
| 14 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.05624797 |
| 15 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.04955954 |
| 16 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.04213003 |
| 17 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.01281608 |
| 18 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.00666645 |
| 19 | EWS_26573619_Chip-Seq_HEK293_Human | 1.99298962 |
| 20 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.99235948 |
| 21 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.92405390 |
| 22 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.91861331 |
| 23 | FUS_26573619_Chip-Seq_HEK293_Human | 1.85242392 |
| 24 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.81685661 |
| 25 | P300_19829295_ChIP-Seq_ESCs_Human | 1.79233375 |
| 26 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.77699655 |
| 27 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.75055361 |
| 28 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.72739356 |
| 29 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.72165155 |
| 30 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.69831080 |
| 31 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.67346271 |
| 32 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.67346271 |
| 33 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.66933449 |
| 34 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.61889190 |
| 35 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.60636646 |
| 36 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.59275249 |
| 37 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.57396262 |
| 38 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.55040275 |
| 39 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.52292162 |
| 40 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.51279223 |
| 41 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.51279223 |
| 42 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.45418846 |
| 43 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.43000076 |
| 44 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.42230769 |
| 45 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.34777635 |
| 46 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.33769625 |
| 47 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.31751989 |
| 48 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.31211550 |
| 49 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.30961645 |
| 50 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.30449660 |
| 51 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.29144349 |
| 52 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.27556931 |
| 53 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.27477119 |
| 54 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.25532954 |
| 55 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.24703349 |
| 56 | STAT3_23295773_ChIP-Seq_U87_Human | 1.24302730 |
| 57 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.22039831 |
| 58 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.21515917 |
| 59 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.21336539 |
| 60 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.20020537 |
| 61 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.19979800 |
| 62 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.19293980 |
| 63 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.18652720 |
| 64 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.18497046 |
| 65 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.17581149 |
| 66 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.16610824 |
| 67 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.16335968 |
| 68 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.16335968 |
| 69 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.16310546 |
| 70 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.15840524 |
| 71 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 1.15267026 |
| 72 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.14253253 |
| 73 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.13714632 |
| 74 | TCF4_23295773_ChIP-Seq_U87_Human | 1.12618288 |
| 75 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.09122042 |
| 76 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.08129055 |
| 77 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.07915501 |
| 78 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.07891058 |
| 79 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.07563898 |
| 80 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.07308665 |
| 81 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.06790226 |
| 82 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.06071557 |
| 83 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.05243135 |
| 84 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.03842651 |
| 85 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.03513493 |
| 86 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.02400215 |
| 87 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.01982388 |
| 88 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.01073756 |
| 89 | AR_25329375_ChIP-Seq_VCAP_Human | 1.00502024 |
| 90 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.99881662 |
| 91 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.99844732 |
| 92 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.99768626 |
| 93 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.99764135 |
| 94 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.99065905 |
| 95 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.98871645 |
| 96 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.97880600 |
| 97 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.97564273 |
| 98 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.96641546 |
| 99 | NCOR_22424771_ChIP-Seq_293T_Human | 0.96521610 |
| 100 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.94775308 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000372_irregular_coat_pigmentation | 4.33189491 |
| 2 | MP0009379_abnormal_foot_pigmentation | 3.10186628 |
| 3 | MP0002837_dystrophic_cardiac_calcinosis | 2.98726031 |
| 4 | MP0004043_abnormal_pH_regulation | 2.88017089 |
| 5 | MP0002138_abnormal_hepatobiliary_system | 2.51894025 |
| 6 | MP0004885_abnormal_endolymph | 2.23684957 |
| 7 | MP0003195_calcinosis | 2.18582281 |
| 8 | MP0002234_abnormal_pharynx_morphology | 2.07519082 |
| 9 | MP0003880_abnormal_central_pattern | 2.05798244 |
| 10 | MP0006276_abnormal_autonomic_nervous | 2.04800075 |
| 11 | MP0001968_abnormal_touch/_nociception | 2.02649007 |
| 12 | MP0002822_catalepsy | 1.98226442 |
| 13 | MP0002735_abnormal_chemical_nociception | 1.98092384 |
| 14 | MP0003787_abnormal_imprinting | 1.96337398 |
| 15 | MP0001188_hyperpigmentation | 1.88598654 |
| 16 | MP0000569_abnormal_digit_pigmentation | 1.75950925 |
| 17 | MP0006054_spinal_hemorrhage | 1.72235046 |
| 18 | MP0002095_abnormal_skin_pigmentation | 1.69485210 |
| 19 | MP0005671_abnormal_response_to | 1.68229364 |
| 20 | MP0001764_abnormal_homeostasis | 1.67483293 |
| 21 | MP0005551_abnormal_eye_electrophysiolog | 1.58012827 |
| 22 | MP0005645_abnormal_hypothalamus_physiol | 1.50454982 |
| 23 | MP0003646_muscle_fatigue | 1.50174174 |
| 24 | MP0002277_abnormal_respiratory_mucosa | 1.49711166 |
| 25 | MP0002733_abnormal_thermal_nociception | 1.48654095 |
| 26 | MP0008875_abnormal_xenobiotic_pharmacok | 1.44805825 |
| 27 | MP0006072_abnormal_retinal_apoptosis | 1.42579696 |
| 28 | MP0008872_abnormal_physiological_respon | 1.36884646 |
| 29 | MP0004484_altered_response_of | 1.34940269 |
| 30 | MP0009745_abnormal_behavioral_response | 1.34506596 |
| 31 | MP0003693_abnormal_embryo_hatching | 1.34000054 |
| 32 | MP0000427_abnormal_hair_cycle | 1.32774055 |
| 33 | MP0002572_abnormal_emotion/affect_behav | 1.29932493 |
| 34 | MP0005253_abnormal_eye_physiology | 1.28264586 |
| 35 | MP0004142_abnormal_muscle_tone | 1.27822552 |
| 36 | MP0002184_abnormal_innervation | 1.26289394 |
| 37 | MP0002102_abnormal_ear_morphology | 1.23287444 |
| 38 | MP0005386_behavior/neurological_phenoty | 1.23126604 |
| 39 | MP0004924_abnormal_behavior | 1.23126604 |
| 40 | MP0002736_abnormal_nociception_after | 1.21731372 |
| 41 | MP0000015_abnormal_ear_pigmentation | 1.21709209 |
| 42 | MP0005075_abnormal_melanosome_morpholog | 1.21269046 |
| 43 | MP0002638_abnormal_pupillary_reflex | 1.21030569 |
| 44 | MP0001905_abnormal_dopamine_level | 1.20801903 |
| 45 | MP0000778_abnormal_nervous_system | 1.19847295 |
| 46 | MP0003045_fibrosis | 1.17874524 |
| 47 | MP0001970_abnormal_pain_threshold | 1.16785127 |
| 48 | MP0005174_abnormal_tail_pigmentation | 1.15882188 |
| 49 | MP0002272_abnormal_nervous_system | 1.15451619 |
| 50 | MP0008877_abnormal_DNA_methylation | 1.13751664 |
| 51 | MP0000647_abnormal_sebaceous_gland | 1.13156761 |
| 52 | MP0001324_abnormal_eye_pigmentation | 1.11905349 |
| 53 | MP0002168_other_aberrant_phenotype | 1.08590369 |
| 54 | MP0006036_abnormal_mitochondrial_physio | 1.06438697 |
| 55 | MP0006292_abnormal_olfactory_placode | 1.03156115 |
| 56 | MP0005220_abnormal_exocrine_pancreas | 1.02517028 |
| 57 | MP0009764_decreased_sensitivity_to | 1.02492287 |
| 58 | MP0002938_white_spotting | 1.01925208 |
| 59 | MP0003136_yellow_coat_color | 1.00661829 |
| 60 | MP0008995_early_reproductive_senescence | 0.99769952 |
| 61 | MP0002148_abnormal_hypersensitivity_rea | 0.98856417 |
| 62 | MP0003011_delayed_dark_adaptation | 0.98659887 |
| 63 | MP0001501_abnormal_sleep_pattern | 0.97391321 |
| 64 | MP0004782_abnormal_surfactant_physiolog | 0.96673164 |
| 65 | MP0010386_abnormal_urinary_bladder | 0.94867061 |
| 66 | MP0003252_abnormal_bile_duct | 0.93470550 |
| 67 | MP0002063_abnormal_learning/memory/cond | 0.90652011 |
| 68 | MP0003635_abnormal_synaptic_transmissio | 0.90160875 |
| 69 | MP0008775_abnormal_heart_ventricle | 0.89735222 |
| 70 | MP0000049_abnormal_middle_ear | 0.86819520 |
| 71 | MP0009046_muscle_twitch | 0.86617724 |
| 72 | MP0001944_abnormal_pancreas_morphology | 0.86261870 |
| 73 | MP0000613_abnormal_salivary_gland | 0.86108789 |
| 74 | MP0003638_abnormal_response/metabolism_ | 0.85945561 |
| 75 | MP0000631_abnormal_neuroendocrine_gland | 0.85745562 |
| 76 | MP0002160_abnormal_reproductive_system | 0.85647108 |
| 77 | MP0001986_abnormal_taste_sensitivity | 0.85070769 |
| 78 | MP0005395_other_phenotype | 0.84879206 |
| 79 | MP0001835_abnormal_antigen_presentation | 0.84695001 |
| 80 | MP0010329_abnormal_lipoprotein_level | 0.84275499 |
| 81 | MP0009250_abnormal_appendicular_skeleto | 0.83743860 |
| 82 | MP0003718_maternal_effect | 0.83405561 |
| 83 | MP0002249_abnormal_larynx_morphology | 0.83365355 |
| 84 | MP0003567_abnormal_fetal_cardiomyocyte | 0.82647685 |
| 85 | MP0002557_abnormal_social/conspecific_i | 0.81031642 |
| 86 | MP0001529_abnormal_vocalization | 0.79205864 |
| 87 | MP0008569_lethality_at_weaning | 0.77129153 |
| 88 | MP0008058_abnormal_DNA_repair | 0.76652370 |
| 89 | MP0003186_abnormal_redox_activity | 0.75800265 |
| 90 | MP0005389_reproductive_system_phenotype | 0.75670186 |
| 91 | MP0003119_abnormal_digestive_system | 0.74448986 |
| 92 | MP0003724_increased_susceptibility_to | 0.74351209 |
| 93 | MP0002233_abnormal_nose_morphology | 0.73571214 |
| 94 | MP0000230_abnormal_systemic_arterial | 0.72078207 |
| 95 | MP0001984_abnormal_olfaction | 0.71893874 |
| 96 | MP0003890_abnormal_embryonic-extraembry | 0.71703359 |
| 97 | MP0002752_abnormal_somatic_nervous | 0.70090756 |
| 98 | MP0003806_abnormal_nucleotide_metabolis | 0.69994747 |
| 99 | MP0005646_abnormal_pituitary_gland | 0.69040414 |
| 100 | MP0003786_premature_aging | 0.68542696 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ketoacidosis (HP:0001993) | 4.49370666 |
| 2 | Reduced antithrombin III activity (HP:0001976) | 4.23814040 |
| 3 | Pancreatic cysts (HP:0001737) | 3.88763423 |
| 4 | Ketosis (HP:0001946) | 3.63948947 |
| 5 | Amyotrophic lateral sclerosis (HP:0007354) | 3.63381958 |
| 6 | Methylmalonic acidemia (HP:0002912) | 3.56041432 |
| 7 | Pancreatic fibrosis (HP:0100732) | 3.43956123 |
| 8 | Hyperglycinemia (HP:0002154) | 3.38755732 |
| 9 | Stomatitis (HP:0010280) | 3.30453400 |
| 10 | Acute necrotizing encephalopathy (HP:0006965) | 3.26923978 |
| 11 | Type I transferrin isoform profile (HP:0003642) | 3.25254806 |
| 12 | Progressive macrocephaly (HP:0004481) | 3.17445214 |
| 13 | Dry hair (HP:0011359) | 3.14159403 |
| 14 | Conical tooth (HP:0000698) | 3.08500754 |
| 15 | Methylmalonic aciduria (HP:0012120) | 3.06292858 |
| 16 | Volvulus (HP:0002580) | 3.05451000 |
| 17 | Molar tooth sign on MRI (HP:0002419) | 3.04536310 |
| 18 | Abnormality of midbrain morphology (HP:0002418) | 3.04536310 |
| 19 | Testicular atrophy (HP:0000029) | 3.03704603 |
| 20 | Amelogenesis imperfecta (HP:0000705) | 2.90239310 |
| 21 | True hermaphroditism (HP:0010459) | 2.89379451 |
| 22 | Abolished electroretinogram (ERG) (HP:0000550) | 2.88987509 |
| 23 | Congenital stationary night blindness (HP:0007642) | 2.81353199 |
| 24 | Decreased central vision (HP:0007663) | 2.77019714 |
| 25 | Thyroiditis (HP:0100646) | 2.76084457 |
| 26 | Type 2 muscle fiber atrophy (HP:0003554) | 2.69964129 |
| 27 | Long nose (HP:0003189) | 2.67654505 |
| 28 | Abnormality of the renal cortex (HP:0011035) | 2.67119098 |
| 29 | Abnormal protein glycosylation (HP:0012346) | 2.66933998 |
| 30 | Abnormal glycosylation (HP:0012345) | 2.66933998 |
| 31 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.66933998 |
| 32 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.66933998 |
| 33 | Attenuation of retinal blood vessels (HP:0007843) | 2.65753674 |
| 34 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.64073152 |
| 35 | Acute encephalopathy (HP:0006846) | 2.63742615 |
| 36 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.57048976 |
| 37 | Tachypnea (HP:0002789) | 2.53040393 |
| 38 | Optic disc pallor (HP:0000543) | 2.51735397 |
| 39 | Broad-based gait (HP:0002136) | 2.50917317 |
| 40 | Abnormality of the prostate (HP:0008775) | 2.50824743 |
| 41 | Renal cortical cysts (HP:0000803) | 2.48937908 |
| 42 | Severe combined immunodeficiency (HP:0004430) | 2.48005912 |
| 43 | Pendular nystagmus (HP:0012043) | 2.47007870 |
| 44 | Pachygyria (HP:0001302) | 2.46427358 |
| 45 | Nephronophthisis (HP:0000090) | 2.43688235 |
| 46 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.40819909 |
| 47 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.40819909 |
| 48 | Lissencephaly (HP:0001339) | 2.40433451 |
| 49 | Decreased circulating renin level (HP:0003351) | 2.33897066 |
| 50 | Aplastic anemia (HP:0001915) | 2.30210337 |
| 51 | Abnormality of macular pigmentation (HP:0008002) | 2.26455910 |
| 52 | Inability to walk (HP:0002540) | 2.25377497 |
| 53 | Pancytopenia (HP:0001876) | 2.22317513 |
| 54 | Cystic liver disease (HP:0006706) | 2.18070873 |
| 55 | Abnormality of the renal medulla (HP:0100957) | 2.17081512 |
| 56 | Choroideremia (HP:0001139) | 2.16669633 |
| 57 | Abnormality of glycine metabolism (HP:0010895) | 2.16008004 |
| 58 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.16008004 |
| 59 | Abnormal drinking behavior (HP:0030082) | 2.15815448 |
| 60 | Polydipsia (HP:0001959) | 2.15815448 |
| 61 | Mitochondrial inheritance (HP:0001427) | 2.15182425 |
| 62 | Abnormality of DNA repair (HP:0003254) | 2.15097806 |
| 63 | Metaphyseal dysplasia (HP:0100255) | 2.14162106 |
| 64 | Hypoproteinemia (HP:0003075) | 2.13844641 |
| 65 | Generalized aminoaciduria (HP:0002909) | 2.12472309 |
| 66 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.11932099 |
| 67 | Muscle fiber atrophy (HP:0100295) | 2.10095011 |
| 68 | Cerebral edema (HP:0002181) | 2.09946769 |
| 69 | Constricted visual fields (HP:0001133) | 2.07678999 |
| 70 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.06677171 |
| 71 | Progressive inability to walk (HP:0002505) | 2.01472473 |
| 72 | Abnormality of the corticospinal tract (HP:0002492) | 1.97840400 |
| 73 | Chorioretinal atrophy (HP:0000533) | 1.93549408 |
| 74 | Muscular hypotonia of the trunk (HP:0008936) | 1.92850834 |
| 75 | Increased CSF lactate (HP:0002490) | 1.92382581 |
| 76 | Tubular atrophy (HP:0000092) | 1.91164360 |
| 77 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.89536391 |
| 78 | Polyuria (HP:0000103) | 1.89034433 |
| 79 | Abnormality of eosinophils (HP:0001879) | 1.86897247 |
| 80 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.86489444 |
| 81 | Abnormality of vitamin B metabolism (HP:0004340) | 1.86352659 |
| 82 | Febrile seizures (HP:0002373) | 1.86163096 |
| 83 | Autoimmune hemolytic anemia (HP:0001890) | 1.85663219 |
| 84 | Autoimmune thrombocytopenia (HP:0001973) | 1.84443813 |
| 85 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.82271459 |
| 86 | Albinism (HP:0001022) | 1.82034833 |
| 87 | Concave nail (HP:0001598) | 1.77843423 |
| 88 | Congenital sensorineural hearing impairment (HP:0008527) | 1.75923859 |
| 89 | Hypoplastic iliac wings (HP:0002866) | 1.75811467 |
| 90 | Keratoconus (HP:0000563) | 1.75294666 |
| 91 | Increased corneal curvature (HP:0100692) | 1.75294666 |
| 92 | Hypokalemic alkalosis (HP:0001949) | 1.73816408 |
| 93 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.73794942 |
| 94 | Severe visual impairment (HP:0001141) | 1.73628141 |
| 95 | Abnormal biliary tract physiology (HP:0012439) | 1.70998232 |
| 96 | Bile duct proliferation (HP:0001408) | 1.70998232 |
| 97 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.70869500 |
| 98 | Prostate neoplasm (HP:0100787) | 1.70751763 |
| 99 | Poor speech (HP:0002465) | 1.69914375 |
| 100 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.69059240 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 4.08440685 |
| 2 | MARK1 | 3.93654049 |
| 3 | FRK | 3.85751211 |
| 4 | MAP3K9 | 3.79562411 |
| 5 | TAOK3 | 3.64859663 |
| 6 | PNCK | 2.85774708 |
| 7 | ZAK | 2.62579852 |
| 8 | TNIK | 2.57161203 |
| 9 | ADRBK2 | 2.29571420 |
| 10 | BCR | 2.17387803 |
| 11 | TAF1 | 2.15776206 |
| 12 | PIK3CG | 2.12961690 |
| 13 | TLK1 | 2.08971806 |
| 14 | GRK1 | 1.92641800 |
| 15 | BUB1 | 1.85932668 |
| 16 | TGFBR2 | 1.64826090 |
| 17 | BCKDK | 1.61851100 |
| 18 | KDR | 1.61037075 |
| 19 | NUAK1 | 1.58878139 |
| 20 | VRK2 | 1.57972166 |
| 21 | MAP4K2 | 1.53608150 |
| 22 | LATS1 | 1.44440132 |
| 23 | CDC42BPA | 1.43402121 |
| 24 | VRK1 | 1.39022132 |
| 25 | TESK2 | 1.16319116 |
| 26 | TXK | 1.15296604 |
| 27 | ADRBK1 | 1.12615339 |
| 28 | DYRK2 | 1.12162584 |
| 29 | AKT3 | 1.06909502 |
| 30 | SRPK1 | 1.02743233 |
| 31 | STK38L | 1.02020093 |
| 32 | CLK1 | 1.00963888 |
| 33 | INSRR | 0.97255866 |
| 34 | GRK5 | 0.96913957 |
| 35 | ITK | 0.92849000 |
| 36 | CSNK1A1L | 0.91061853 |
| 37 | SGK2 | 0.90516651 |
| 38 | FGFR2 | 0.89573133 |
| 39 | CDK3 | 0.89303107 |
| 40 | MATK | 0.87733294 |
| 41 | WNK4 | 0.85785854 |
| 42 | OXSR1 | 0.84102572 |
| 43 | STK16 | 0.82268722 |
| 44 | PINK1 | 0.80066529 |
| 45 | KIT | 0.79958781 |
| 46 | WNK3 | 0.78857609 |
| 47 | FES | 0.76986129 |
| 48 | TIE1 | 0.72281752 |
| 49 | GRK6 | 0.71362453 |
| 50 | CAMK1G | 0.70614776 |
| 51 | NLK | 0.69727628 |
| 52 | STK39 | 0.68802140 |
| 53 | CSNK1G3 | 0.67998181 |
| 54 | LCK | 0.66802646 |
| 55 | TEC | 0.65004977 |
| 56 | CSNK1G1 | 0.64783985 |
| 57 | BMPR1B | 0.64696743 |
| 58 | RPS6KA4 | 0.64640371 |
| 59 | CSNK1G2 | 0.63907850 |
| 60 | PRKCE | 0.63787834 |
| 61 | EPHA4 | 0.63644549 |
| 62 | MAP2K7 | 0.63612037 |
| 63 | ACVR1B | 0.61781897 |
| 64 | RPS6KA5 | 0.61628491 |
| 65 | AURKA | 0.61603118 |
| 66 | MAPK13 | 0.59928224 |
| 67 | ABL1 | 0.58496828 |
| 68 | EIF2AK3 | 0.58219782 |
| 69 | ERBB3 | 0.57256596 |
| 70 | PHKG1 | 0.57204133 |
| 71 | PHKG2 | 0.57204133 |
| 72 | GRK7 | 0.57142671 |
| 73 | WNK1 | 0.56580416 |
| 74 | RPS6KA6 | 0.55541176 |
| 75 | SGK223 | 0.53870754 |
| 76 | SGK494 | 0.53870754 |
| 77 | IKBKE | 0.52216591 |
| 78 | CAMK2A | 0.51957149 |
| 79 | NTRK2 | 0.51190476 |
| 80 | SYK | 0.51036492 |
| 81 | MKNK1 | 0.50893329 |
| 82 | PLK4 | 0.47812011 |
| 83 | HCK | 0.46918833 |
| 84 | STK3 | 0.45446162 |
| 85 | IKBKB | 0.44596386 |
| 86 | ATM | 0.43960571 |
| 87 | OBSCN | 0.43813796 |
| 88 | RPS6KC1 | 0.43720980 |
| 89 | RPS6KL1 | 0.43720980 |
| 90 | PRKCG | 0.43576281 |
| 91 | SCYL2 | 0.41749054 |
| 92 | PRKCQ | 0.40762324 |
| 93 | DDR2 | 0.40659698 |
| 94 | MINK1 | 0.39763673 |
| 95 | PRKCH | 0.39277421 |
| 96 | PRKACA | 0.36039116 |
| 97 | PIK3CA | 0.35490748 |
| 98 | PRKDC | 0.32542797 |
| 99 | ALK | 0.32317950 |
| 100 | PLK2 | 0.31771068 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.85771613 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 2.75976757 |
| 3 | Asthma_Homo sapiens_hsa05310 | 2.66588962 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.66342539 |
| 5 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.51418896 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.41135846 |
| 7 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.40978742 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.40146295 |
| 9 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.20313262 |
| 10 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.08016404 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.05867042 |
| 12 | Proteasome_Homo sapiens_hsa03050 | 2.03512082 |
| 13 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.02256833 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.99994328 |
| 15 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.81577059 |
| 16 | Protein export_Homo sapiens_hsa03060 | 1.73380443 |
| 17 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.70405004 |
| 18 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.61311865 |
| 19 | Parkinsons disease_Homo sapiens_hsa05012 | 1.60638128 |
| 20 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.58124899 |
| 21 | Taste transduction_Homo sapiens_hsa04742 | 1.55015354 |
| 22 | RNA degradation_Homo sapiens_hsa03018 | 1.54765355 |
| 23 | Phototransduction_Homo sapiens_hsa04744 | 1.53828324 |
| 24 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.46275269 |
| 25 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.42771259 |
| 26 | RNA polymerase_Homo sapiens_hsa03020 | 1.36525776 |
| 27 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.36309185 |
| 28 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.31822133 |
| 29 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.31026502 |
| 30 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.26559273 |
| 31 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.26203776 |
| 32 | Alzheimers disease_Homo sapiens_hsa05010 | 1.22402796 |
| 33 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.20982836 |
| 34 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.20873866 |
| 35 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.17604064 |
| 36 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.14237440 |
| 37 | Viral myocarditis_Homo sapiens_hsa05416 | 1.13378526 |
| 38 | Morphine addiction_Homo sapiens_hsa05032 | 1.12211013 |
| 39 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.10982986 |
| 40 | Salivary secretion_Homo sapiens_hsa04970 | 1.05569745 |
| 41 | Nicotine addiction_Homo sapiens_hsa05033 | 1.04145995 |
| 42 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.03951663 |
| 43 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.03824601 |
| 44 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.03265458 |
| 45 | Olfactory transduction_Homo sapiens_hsa04740 | 1.02571608 |
| 46 | Homologous recombination_Homo sapiens_hsa03440 | 0.97630174 |
| 47 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.97154537 |
| 48 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.96281583 |
| 49 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.95782684 |
| 50 | Huntingtons disease_Homo sapiens_hsa05016 | 0.94673593 |
| 51 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.92749960 |
| 52 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.91683783 |
| 53 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.90741155 |
| 54 | Basal transcription factors_Homo sapiens_hsa03022 | 0.88620085 |
| 55 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.86396183 |
| 56 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.85951436 |
| 57 | Insulin secretion_Homo sapiens_hsa04911 | 0.85833092 |
| 58 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.85759811 |
| 59 | Peroxisome_Homo sapiens_hsa04146 | 0.85193547 |
| 60 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.83370576 |
| 61 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.83285273 |
| 62 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.81866041 |
| 63 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.81641428 |
| 64 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.81137004 |
| 65 | Ribosome_Homo sapiens_hsa03010 | 0.78876372 |
| 66 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.78715239 |
| 67 | Purine metabolism_Homo sapiens_hsa00230 | 0.77457572 |
| 68 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.74017558 |
| 69 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.72534338 |
| 70 | Circadian entrainment_Homo sapiens_hsa04713 | 0.71579488 |
| 71 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.69090605 |
| 72 | Retinol metabolism_Homo sapiens_hsa00830 | 0.68125017 |
| 73 | GABAergic synapse_Homo sapiens_hsa04727 | 0.66580198 |
| 74 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.66504041 |
| 75 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.64547084 |
| 76 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.63296854 |
| 77 | RNA transport_Homo sapiens_hsa03013 | 0.61466385 |
| 78 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.58357614 |
| 79 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.56220930 |
| 80 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.55974373 |
| 81 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.55826764 |
| 82 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.55683868 |
| 83 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.55515144 |
| 84 | Renin secretion_Homo sapiens_hsa04924 | 0.55435970 |
| 85 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.52413979 |
| 86 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.52081125 |
| 87 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.50173183 |
| 88 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.49609273 |
| 89 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.47313801 |
| 90 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.45581355 |
| 91 | Metabolic pathways_Homo sapiens_hsa01100 | 0.41737067 |
| 92 | ABC transporters_Homo sapiens_hsa02010 | 0.41094463 |
| 93 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.36345172 |
| 94 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.34796731 |
| 95 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.33064402 |
| 96 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.32447852 |
| 97 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.31182084 |
| 98 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.29212407 |
| 99 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.27846287 |
| 100 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.26815644 |

